Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
about
G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients.New G-CSF agonists for neutropenia therapy.Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population.Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery.Evaluation of pegfilgrastim use at an academic medical center.Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.
P2860
Q34982532-70949B37-694B-44E3-A30D-E79B31719FBEQ36007020-56982007-E49A-4432-95D4-D6F5A63D9D49Q38145338-DFD9794B-60AE-4C0F-B742-177E2A15F629Q38225700-408FF617-5EB9-4CD2-8AE8-5650A294D5B8Q39074316-46412803-6915-4105-9A90-2B036E1605C9Q41139035-BDBA26C0-C13D-4B6A-A48E-835B40AE1B74Q42267665-D2524C97-6FB9-42CE-8A6C-972C8E9413F0Q50509522-E3F85FBD-BFC1-4B6B-99B2-6BD0E19A981EQ50584736-F62DADE1-9334-4251-AD52-5609B64ED8BDQ53559623-EEB06150-8B88-4D1D-A9DA-EF7F3002B4A9
P2860
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
@en
type
label
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
@en
prefLabel
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
@en
P2860
P1433
P1476
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
@en
P2093
Bradford R Hirsch
Gary H Lyman
P2860
P304
P356
10.2165/11590130-000000000-00000
P577
2012-06-01T00:00:00Z
P6179
1050356126